Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Berkowitz

Showing results (481-490 of 497) with videos related to

Pageof 50
Sort By:
The New England Journal of Medicine|March 30, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P Bonaca, Rupert M Bauersachs, Sonia S Anand, et al.
Journal of Vascular Surgery|December 5, 2022
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduitsNicholas Govsyeyev, Mark Nehler, Michael S Conte, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 18, 2021
Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudyMukul Sharma, Eric E Smith, Lesly A Pearce, et al.
Blood Advances|October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Circulation|August 12, 2021
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD TrialE Sebastian Debus, Mark R Nehler, Nicholas Govsyeyev, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 4, 2016
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global RegistryKanjana S Perera, Thomas Vanassche, Jackie Bosch, et al.
Pediatrics|February 11, 1998
Shaken baby syndrome--a forensic pediatric responseD L Chadwick, R H Kirschner, R M Reece, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Vascular Medicine (London, England)|March 17, 2024
Methods, design, and initial results of an angiographic core lab from VOYAGER-PADR Kevin Rogers, Joerg Herold, Nicholas Govsyeyev, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
Pageof 50

Showing results (481-490 of 497) with videos related to

Sort By:
Pageof 50
The New England Journal of Medicine|March 30, 2020
Rivaroxaban in Peripheral Artery Disease after RevascularizationMarc P Bonaca, Rupert M Bauersachs, Sonia S Anand, et al.
Journal of Vascular Surgery|December 5, 2022
Rivaroxaban in patients with symptomatic peripheral artery disease after lower extremity bypass surgery with venous and prosthetic conduitsNicholas Govsyeyev, Mark Nehler, Michael S Conte, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|November 18, 2021
Rivaroxaban versus aspirin for prevention of covert brain infarcts in patients with embolic stroke of undetermined source: NAVIGATE ESUS MRI substudyMukul Sharma, Eric E Smith, Lesly A Pearce, et al.
Blood Advances|October 1, 2020
Safety and efficacy of anticoagulant therapy in pediatric catheter-related venous thrombosis (EINSTEIN-Jr CVC-VTE)Katharina Thom, Anthonie W A Lensing, Ildar Nurmeev, et al.
Circulation|August 12, 2021
Effect of Rivaroxaban and Aspirin in Patients With Peripheral Artery Disease Undergoing Surgical Revascularization: Insights From the VOYAGER PAD TrialE Sebastian Debus, Mark R Nehler, Nicholas Govsyeyev, et al.
International Journal of Stroke : Official Journal of the International Stroke Society|June 4, 2016
Embolic strokes of undetermined source: Prevalence and patient features in the ESUS Global RegistryKanjana S Perera, Thomas Vanassche, Jackie Bosch, et al.
Pediatrics|February 11, 1998
Shaken baby syndrome--a forensic pediatric responseD L Chadwick, R H Kirschner, R M Reece, et al.
JAMA Neurology|April 9, 2019
Recurrent Stroke With Rivaroxaban Compared With Aspirin According to Predictors of Atrial Fibrillation: Secondary Analysis of the NAVIGATE ESUS Randomized Clinical TrialJeff S Healey, David J Gladstone, Balakumar Swaminathan, et al.
Vascular Medicine (London, England)|March 17, 2024
Methods, design, and initial results of an angiographic core lab from VOYAGER-PADR Kevin Rogers, Joerg Herold, Nicholas Govsyeyev, et al.
Journal of Thrombosis and Haemostasis : JTH|April 5, 2020
Rivaroxaban for treatment of pediatric venous thromboembolism. An Einstein-Jr phase 3 dose-exposure-response evaluationGuy Young, Anthonie W A Lensing, Paul Monagle, et al.
Pageof 50